Thesis TrackerLoading companies…
All companies
Loading…
Thesis TrackerThesis TrackerLoading…
Sigma Healthcare (ASX:SIG), the merged Chemist Warehouse and Sigma group, is one of the most debated healthcare stocks among fund managers. In August 2026, Pendal Group reported a small 2% miss for FY26 as May and June sales growth slowed from around 14% to 8-9%, driven by a late flu season. Ten Cap named Sigma its top buy idea after weakness linked to reports it was evaluating a bid for UK chemist chain Boots, viewing its decision to walk away as evidence of management discipline. Antares noted founder commitments around escrowed shares eased overhang concerns. Sigma Healthcare operates in the Healthcare sector within the Healthcare Providers and Services industry, and Thesis Tracker has captured 38 comments from 15 fund managers, including Pendal Group, Ten Cap, Antares and Kardinia. Headquartered in Clayton, Melbourne, Sigma operates the Chemist Warehouse retail network and pharmaceutical wholesale and distribution businesses.
Company figures as of 15 Oct 2026. For information only.
Fund managers including Ten Cap, Milford Asset Management, Cooper Investors, Airlie Funds Management, Wilson Asset Management, Hyperion Asset Management, ELM Responsible Investments, Pendal Group, Antares Capital, Investors Mutual Limited, Paradice Investment Management, Greencape Capital, Alliance Bernstein, Quest Asset Partners, Alvia Asset Partners and Kardinia Capital have invested in Sigma Healthcare Ltd (ASX:SIG).
Ten Cap and Kardinia highlight the strength and scale of the Chemist Warehouse network and management discipline in walking away from the Boots process, while Antares notes founder commitments reduced concerns about the release of over five billion escrowed shares.
Pendal notes slowing sales growth late in FY26 caused a small earnings miss, and the market reacted negatively to the possibility of a large, high-risk acquisition of Boots that could have diluted returns. Sigma's premium valuation leaves little room for disappointment.
Sigma Healthcare Ltd. is an Australian pharmaceutical company founded in 1912 and headquartered in Clayton. The firm specializes in the manufacturing and wholesale distribution of pharmaceutical products and medical consumables to community pharmacies and grocery channels. Additionally, Sigma provides retail support services, private label products, dose administration aids, and data analytics solutions to its pharmacy network. As a distributor, Sigma plays a core role in the Australian healthcare supply chain.
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.